arrow_back Back to App

Treat and Reduce Obesity: Expanding Access to Healthcare

This act aims to improve access to obesity treatment for Medicare beneficiaries. It expands the types of healthcare providers who can offer intensive behavioral therapy and allows for coverage of certain obesity medications under Medicare. This means more people will be able to get the support they need to manage obesity and related health conditions.
Key points
More healthcare professionals, including dietitians, clinical psychologists, physician assistants, and nurse practitioners, will be able to provide intensive behavioral therapy for obesity, with a doctor's referral.
Medicare Part D will cover certain obesity medications or weight loss management drugs for individuals who are overweight and have related health issues.
The act seeks to reduce the costs associated with obesity-related chronic diseases, which currently place a significant burden on the Medicare system and personal finances.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4231
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2025-06-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Treat and Reduce Obesity Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4231.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-27.

What are the main provisions?

Key points include:

  • More healthcare professionals, including dietitians, clinical psychologists, physician assistants, and nurse practitioners, will be able to provide intensive behavioral therapy for obesity, with a doctor's referral.
  • Medicare Part D will cover certain obesity medications or weight loss management drugs for individuals who are overweight and have related health issues.
  • The act seeks to reduce the costs associated with obesity-related chronic diseases, which currently place a significant burden on the Medicare system and personal finances.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health